Abstract

BackgroundAnti-N-methyl-D-aspartate receptor encephalitis is an increasingly common autoimmune disorder mediated by antibodies to certain subunit of the N-methyl-D-aspartate receptor. Recent literatures have described anti-thyroid and infectious serology in this encephalitis but without follow-up.Case presentationA 17-year-old Chinese female patient presented with psychiatric symptoms, memory deficits, behavioral problems and seizures. She then progressed through unresponsiveness, dyskinesias, autonomic instability and central hypoventilation during treatment. Her conventional blood work on admission showed high titers of IgG antibodies to thyroglobulin, thyroid peroxidase and IgM antibodies to Epstein-Barr virus viral capsid antigen. An immature ovarian teratoma was found and removal of the tumor resulted in a full recovery. The final diagnosis of anti-N-methyl-D-aspartate receptor encephalitis was made by the identification of anti-N-methyl-D-aspartate receptor antibodies in her cerebral spinal fluid. Pathology studies of the teratoma revealed N-methyl-D-aspartate receptor subunit 1 positive ectopic immature nervous tissue and Epstein-Barr virus latent infection. She was discharged with symptoms free, but titers of anti-thyroid peroxidase and anti-thyroglobulin antibodies remained elevated. One year after discharge, her serum remained positive for anti-thyroid peroxidase and anti-N-methyl-D-aspartate receptor antibodies, but negative for anti-thyroglobulin antibodies and IgM against Epstein-Barr virus viral capsid antigen.ConclusionsPersistent high titers of anti-thyroid peroxidase antibodies from admission to discharge and until one year later in this patient may suggest a propensity to autoimmunity in anti- N-methyl-D-aspartate receptor encephalitis and support the idea that neuronal and thyroid autoimmunities represent a pathogenic spectrum. Enduring anti-N-methyl-D-aspartate receptor antibodies from admission to one year follow-up but seroreversion of Epstein-Barr virus viral capsid antigen IgM may raise the important issue of elucidating the triggers and boosters of anti- N-methyl-D-aspartate receptor encephalitis.

Highlights

  • Anti-N-methyl-D-aspartate receptor encephalitis is an increasingly common autoimmune disorder mediated by antibodies to certain subunit of the N-methyl-D-aspartate receptor

  • Enduring anti-N-methyl-D-aspartate receptor antibodies from admission to one year follow-up but seroreversion of Epstein-Barr virus viral capsid antigen IgM may raise the important issue of elucidating the triggers and boosters of anti- N-methyl-D-aspartate receptor encephalitis

  • Anti-N-methyl-D-aspartate receptor encephalitis is a newly identified autoimmune encephalitis associated with antibodies against functional NMDA receptors that predominantly affects young females and exhibits a well defined set of clinical

Read more

Summary

Conclusions

Persistent high titers of serum anti-thyroid peroxidase antibodies from admission to discharge and until one year later in our patient may suggest a propensity to autoimmunity in anti-NMDAR encephalitis, but support the notion that neuronal and thyroid autoimmunities represent a pathogenic spectrum. The enduring anti-NMDAR antibodies positivity from admission to one year follow-up, EBV latent infected ovarian teratoma, and seroreversion of EBV-VCA-IgM of current case might raise the issue of elucidating the triggers and boosters of this autoimmune encephalopathy in the future. List of abbreviations anti-NMDAR encephalitis: anti-N-methyl-D-aspartate receptor encephalitis; NR1: N-Methyl-D-aspartate receptor subunit 1; EBV-VCA-IgM: Epstein-Barr virus viral capsid antigen IgM; anti-TPO antibodies: anti-thyroid peroxidase antibodies; anti-TG antibodies: anti-thyroglobulin antibodies; ELISA: enzymelinked immunosorbent assay; HE: Hashimoto encephalopathy; EBV: EpsteinBarr virus; CSF: Cerebrospinal fluid; MRI: magnetic resonance imaging; EEG: electroencephalography; EBER: Epstein-Barr virus encoded RNA; ISH: in situ hybridization; EBV-EA: EBV early antigen; EBNA: EBV nuclear antigen

Background
Limitations
Findings
18. Sébire G
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call